Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: April 28, 2009
Reporting Period: First Quarter of 2009
This filing serves as a notification that the Company issued a press release announcing its financial results for the first quarter of 2009. The press release and supplemental information are incorporated by reference as Exhibits 99.1 and 99.2.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release for details on:
- Revenue
- Profit
- Cash flow
- Margins
- Debt and liquidity
Note: The filing text does not provide clear values for these metrics; they are contained in the referenced Exhibit 99.1.
Material Changes
The filing text does not explicitly detail material changes versus the prior comparable period. It directs investors to the press release (Exhibit 99.1) for the announcement of first-quarter 2009 results.
Guidance, Outlook, and Risks
The text does not include specific guidance, outlook, management commentary, risks, contingencies, or unusual items. These elements are expected to be found in the incorporated press release and supplemental website information.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated April 28, 2009) for specific Q1 2009 revenue and earnings figures.
- Access Exhibit 99.2 for supplemental information posted on the Company's website (www.bms.com).
- Compare Q1 2009 results against Q1 2008 figures to assess year-over-year performance.
- Verify any forward-looking statements or guidance provided in the press release.